PGY2 Cardiology Pharmacy Residency Program Receives Accreditation
Accreditation Services Division of the American Society of Health-System Pharmacists grants important credential for the cardiology pharmacy residency program.
by Stephen Vodhanel, PhD
Under the leadership of Javad Tafreshi, PharmD, BCPS, AQ Cardiology, FAHA, the Loma Linda University’s post-graduate year-two (PGY2) cardiology pharmacy residency program has received accreditation from the American Society of Health-System Pharmacists (ASHP).
ASHP is the only nationally recognized non-governmental, non-profit pharmacy association that has been accrediting pharmacy residencies since 1962.
Accreditation is a very rigorous and meticulous peer-reviewed process that ensures residents are receiving a quality post-graduate education.
Noteworthy is that a decade ago Dr. Tafreshi established the first ASHP-accredited specialty pharmacy residency program in cardiology in the nation. Dr. Tafreshi thanks those who participated in this process, including, but not limited to: Drs. Hughes, Norris, and Hamada for their continuous support of our residency programs; Drs. Pai, Isaeff, Hauschild, Dominguez, Nguyen, and Tan for helping with the accreditation site visit and preparing the required documents.
Also approved during the recent visit from ASHP were the PGY1 and PGY2 Oncology pharmacy residency programs. Drs. Hamada, Dominguez, and Oelschlaeger direct our PGY1 residency and Dr. Michelle Spencer-Safier is the director of our PGY2 Oncology program.
The entire School of Pharmacy congratulates Dr. Tafreshi and the team working towards this important milestone.
More information about ASHP and the value of accreditation is available at http://ashp.org/